- Intensity modulated radiotherapy (IMRT), a form of advanced external beam radiation therapy, is playing an increasingly critical role in modern cancer treatment due to its ability to precisely target tumors while minimizing radiation exposure to surrounding healthy tissues
- The growing demand for IMRT is primarily fueled by the global rise in cancer incidence, increasing adoption of image-guided and adaptive radiotherapy technologies, and a shift toward personalized and minimally invasive treatment approaches
- North America dominated the intensity modulated radiotherapy market with the largest revenue share of 39.8% in 2024, supported by advanced healthcare infrastructure, strong presence of key oncology technology providers, and widespread availability of reimbursement for radiotherapy procedures, with the U.S. leading in both procedure volume and equipment installation
- Asia-Pacific is expected to be the fastest growing region in the intensity modulated radiotherapy market during the forecast period due to rising cancer prevalence, expanding healthcare infrastructure, and increasing public and private investments in advanced radiotherapy technologies
- Photon radiation segment dominated the intensity modulated radiotherapy market by radiation type with a market share of 68.9% in 2024, attributed to its wide clinical usage, technological accessibility, and proven effectiveness across various cancer types
